View Item 

Synthesis and biological activity of fluorinated 7-aryl-2-pyridyl-6,7-dihydro[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-amines.

Access Status
Open access
Authors
Dolzhenko, Anton
Tan, B.
Dolzhenko, A.
Chiu, G.
Chui, W.
Date
2008
Type
Journal Article

Metadata
Show full item record
Citation
Dolzhenko, Anton and Tan, Bee and Dolzhenko, Anna and Chiu, Gigi and Chui, Wai. 2008. Synthesis and biological activity of fluorinated 7-aryl-2-pyridyl-6,7-dihydro[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-amines.. Journal of Fluorine Chemistry. 129 (5): pp. 429-434.
Source Title
Journal of Fluorine Chemistry
DOI
ISSN
School
School of Pharmacy
Remarks

NOTICE: This is the author's version of a work that was accepted for publication in Journal of Fluorine Chemistry. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Journal of Fluorine Chemistry, 129, 5, 2008. DOI: 10.1016/j.jfluchem.2008.02.007

URI
Collection
Abstract

In our lead finding program, 12 new fluorinated 7-aryl-2-pyridyl-6,7-dihydro[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-amines were prepared via a practical three-step procedure starting from (iso)nicotinic hydrazides. The fluorine substituted aryl fragment was introduced in the last step through cyclocondensation of N-(3-pyridyl-1,2,4-triazol-5-yl)guanidines and fluoro/trifluoromethyl substituted benzaldehydes. The structures of the compounds were confirmed by 1H and 13C NMR spectral data. The tautomeric preferences for the compounds were established using 2D NOESY experiments. The antiproliferative activity of the synthesized 1,2,4-triazolo[1,5-a][1,3,5]triazines was evaluated against breast, colon and lung cancer cell lines. The highest antiproliferative activity in the series was found for 2-(pyridine-3-yl)-7-(4-trifluoromethylphenyl)-6,7-dihydro[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-amine. The lack of inhibitory activity against bovine dihydrofolate reductase (DHFR) indicated that the antiproliferative activity was realized via other mechanisms.